Turkish Airlines Open App is Now Available on Mobile Platforms NEW YORK - Thursday, December 19th 2013 [ME NewsWire] (BUSINESS WIRE) The Turkish Airlines Open 2013, the European Tour’s new U.S. $7 million event was full of exciting moments. Held in Antalya between 7-10 November, the tournament included the participation of Tiger Woods and ended with the championship of French golfer, Victor Dubuisson. A Turkish Airlines Open Mobile Golf App was introduced for golf lovers at the start of the event, and is now available free of charge at the Apple App Store; it is compatible with iPhone 3, 4 and 5 as well as iPad2 and its subsequent upgrades. An Android-based release will be available soon. The Turkish Airlines Open mobile golf application allows players to compete with rivals on links that are identical to the Maxx Royal course where the event was played. The App includes real course simulations and stunning visuals that will make it a favorite of golfers wo
...
Read more »
|
ME NewsWire / Business Wire CHEVY CHASE, Md - Wednesday, December 18th 2013 MobileMedia Ideas LLC ("MMI”) announced today that MMI has entered into a license and settlement agreement with BlackBerry Limited and BlackBerry Corporation (collectively "Blackberry”), under which MMI’s patent enforcement action against Blackberry in the U.S. District Court for the Northern District of Texas has been settled and dismissed. MobileMedia Ideas LLC MobileMedia Ideas offers convenient access on reasonable terms to a portfolio of inventions covering important features widely used in smart phones, mobile phones and other portable devices including personal computers, laptops, netbooks, personal media players, e-book readers, cameras and hand-held game consoles. For further information, please refer to www.mobilemediaideas.com. Contacts MobileMedia Ideas LLC Tom O’Reilly Tel: 303-200-1710 toreilly@mobilemediaideas.com
...
Read more »
|
LACHEN, Switzerland - Wednesday, December 18th 2013 [ME NewsWire] (BUSINESS WIRE)-- Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis (RMS). Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable. This randomised, active-controlled phase II/III study aims to confirm preliminary results that suggested it is possible to identify potential responders to treatment with Octagam 5%. Using a combination of functional genomic and protein expression tests, a special assay panel, Heidelberg Assay Panel (HAP), was developed that could potentially stratify patients into predicted responders or non-responders. These laboratory-based tests require just a simple
...
Read more »
Views:
321
|
Added by:
africa-live
|
Date:
12.19.2013
|
|
ABU DHABI, United Arab Emirates - Wednesday, December 18th 2013 [ME NewsWire] To mark the 20th anniversary of its establishment, the Emirates Center for Strategic Studies and Research (ECSSR) held a press conference on Wednesday, under the auspices of His Highness General Sheikh Mohammed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi, Deputy Supreme Commander of the UAE Armed Forces, and President of the ECSSR. A big crowd of journalists, reporters and specialists in intellect, culture and scientific research attended the conference, which featured a documentary on the center and its achievements over the past 20 years. In his opening speech, ECSSR Director General, H.E. Dr. Jamal Sanad Al-Suwaidi, said: "Our sustained pursuit of excellence is the fruit of exerted efforts and dedication over 20 years spent overcoming challenges to achieve our goals, in light of the ECSSR’s ambition and determination to confirm its prestigious status, not only locally and regionally, but
...
Read more »
|
SHENZHEN, China - Wednesday, December 18th 2013 [ME NewsWire] (BUSINESS WIRE) ZTE Corporation and its subsidiary in Germany will appeal a decision by the District Court of Mannheim, Germany this week as the Group continues to defend a patent-related action initiated by Vringo Germany GmbH. The ruling by Mannheim district court concerned the German part of the European Patent EP 1 186 119, owned by Vringo Infrastructure Inc., and a minor and optional function included in certain ZTE products. This week’s decision does not affect ZTE’s ability to offer products without the optional function. As the optional function is not in use in Germany, ZTE customers and consumers will not be affected by the ruling. ZTE will appeal the Mannheim district court ruling in a higher court in Germany, and is optimistic of an outcome in favor of the Group. In parallel, ZTE Deutschland GmbH previously filed a nullity action on the German part of EP 1 186 119 which is still pendin
...
Read more »
| |